Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients

NCT03308591 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

774

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Neoplasm
Cervical Cancer
Uterine Cervical Cancer

Interventions

DRUG: NACT
PROCEDURE: RT+PLND
DRUG: Adjuvant chemotherapy

Sponsor

Huazhong University of Science and Technology